4-phenylbutyric acid has been researched along with carnitine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Finnegan, J; Giva, S; Ihidero, P; Knerr, I; Maguire, G; Monavari, A; Power, B | 1 |
Boussery, K; De Spiegeleer, B; Peeters, E; Remon, JP; Van Tongelen, I; Vanhoorne, V; Vervaet, C; Wynendaele, E | 1 |
Ando, Y; Arisaka, O; Imataka, G; Ishii, J; Nitta, A; Takagi, Y; Yoshihara, S | 1 |
3 other study(ies) available for 4-phenylbutyric acid and carnitine
Article | Year |
---|---|
Hyperammonaemia in Neonates and Young Children: Potential Metabolic Causes, Diagnostic Approaches and Clinical Consequences
Topics: Ammonia; Arginine; Biomarkers; Brain Diseases, Metabolic, Inborn; Carnitine; Critical Illness; Diet, Protein-Restricted; Early Diagnosis; Emergencies; Female; Humans; Hyperammonemia; Infant; Infant, Newborn; Male; Phenylbutyrates; Sodium Benzoate; Treatment Outcome | 2019 |
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.
Topics: Arginine; Belgium; Carnitine; Drug Compounding; Excipients; Humans; Pharmacists; Phenylbutyrates; Primaquine; Pyridoxal Phosphate; Rare Diseases; Sodium Benzoate | 2019 |
Long-term survival of a patient with acute neonatal-onset metabolic encephalopathy with carbamoyl phosphate synthetase 1 deficiency.
Topics: Arginine; Brain Diseases, Metabolic; Carbamoyl-Phosphate Synthase I Deficiency Disease; Carnitine; Female; Humans; Hyperammonemia; Infant, Newborn; Phenylbutyrates; Renal Dialysis; Sodium Benzoate | 2020 |